Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 14, 2025 08:20 ET | Source: Imunon, Inc.

IMUNON to Present Phase 3 Ovarian Cancer Study of IMNN-001 at ESMO Congress

Prestigious European Society for Medical Oncology Conference “trials-in-progress” session Pivotal OVATION 3 trial of its DNA-mediated immunotherapy in newly diagnosed patients underway Company on...